FRA:BC8

Bechtle Ag Stock Signals

etoro logo Buy BC8
*Your capital is at risk
39.12€
-0.98 (-2.44%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.674 1 day ( 0 % )
Last Price 39.12€ -2.44 %
High/ Low 38.40€ - 40.10€ 15.42%
Chg 7 Days 14.19 % $34.26 39.12€
Chg 30 Days 10.88 % $35.28 39.12€
Chg 12 mos 18.55 % $33.00 39.12€
Trend - 3 mos -10.07 % Width: 17.93 %
Trend - 12 mos 18.28 % Width: 24.88 %
Pred. range - 3 mos 30.53€ - 36.00€ -21.96 % - -7.97 %
Pred. range - 12 mos 43.17€ - 53.90€ 10.34 % - 37.79 %
Short MA avg 3 mos Buy Nov 11, 2025 - 5 days
Long MA avg 3 mos Buy Nov 13, 2025 - 3 days
Short/Long MA avg 3 mos Sell Oct 07, 2025 - 30 days
Short MA avg 12 mos Buy Nov 13, 2025 - 3 days
Long MA avg 12 mos Buy Nov 13, 2025 - 3 days
Short/Long MA avg 12 mos Sell Sep 15, 2025 - 46 days
Pivot Short Sell Nov 14, 2025 - 2 days
Bollinger Buy Nov 17, 2025 - 1 day
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT BECHTLE AG
Bechtle AG
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE